Global pharma expects bumper year

Increasing footprints in Vietnam in 2023, multinational corporations continue to eye stronger local partnerships to bring more new innovative medicines and vaccines to the local market in 2024 and beyond.

Related Keywords

Vietnam ,Republic Of ,Switzerland ,Hanoi ,Han I ,Thanh Xuan ,Tuyêquang ,Bach Mai ,Mekong Delta ,Vietnam General ,Germany ,Japan ,Ho Chi Minh City ,H Chíinh ,Swiss ,Vietnamese ,German ,Daiichi Sankyo ,Thomas Gass ,Yukinori Tominaga ,Nguyen Anh Van ,Vietnam Paediatrics Association ,Daiichi Sankyo Vietnam Co Ltd ,Health Dao Hong Lan ,Ministry Of Health ,National Assembly ,Vietlife International ,Novartis ,Vietnam National Heart Association ,Pfizer ,Daiichi Sankyo Vietnam ,Cho Ray Hospital ,Bach Mai Hospital ,Vietnam Vaccine ,Pfizer Vietnam ,Swiss Ambassador ,Vietnam Thomas Gass ,Emerging Markets ,Thanh Xuan General ,Vietlife International General Hospital ,Pharma ,Pharma Groups ,Global Pharma ,